Mitochondrial health connects fat loss and performance, and when mitochondria work better, fat loss happens naturally. Peptide stacking only makes sense when the mechanisms are different, like tesamorelin (growth hormone/IGF-1) and MOTS-c (AMPK/mitochondrial energy sensing), which work through different pathways to improve mitochondrial function.

This study shows that a drug called tesamorelin helps improve energy production in cells by boosting a hormone (IGF-I), which is good for mitochondria—but it didn’t test any other drugs or combinations, so we can’t say stacking it with other peptides works better.

This study showed that MOTS-c helps keep pancreatic cells healthy and functioning longer, which can help delay diabetes.

This study found that MOTS-c helps fix mitochondrial problems in the hearts of mice with type 2 diabetes, which supports the idea that MOTS-c can improve mitochondrial function.

This study shows that a tiny molecule from mitochondria (MOTS-c) helps mice burn fat better and avoid insulin problems, which supports the idea that mitochondria play a key role in weight loss and energy. It doesn’t test combining it with other drugs, but it proves MOTS-c works as described.